Concept: Cutting Cost-Per-Lead Nearly in Half for a 7-Location Dermatology Group

Starting Point

Cascade Dermatology Partners is a fictional dermatology group that grew from two clinics to seven locations across a mid-sized metro area in under three years, blending insurance-based medical dermatology (skin cancer screenings, acne, psoriasis, eczema) with self-pay cosmetic services (Botox, filler, laser resurfacing) under one brand. To keep exam rooms full at every new location, the practice leans hard on Google Ads, but the account was built years ago as a single, blended "Dermatology" campaign covering all seven clinics and both service lines with one shared set of broad keywords. As the group expanded, ad spend scaled up right along with it — without anyone ever going back to rebuild the targeting for a seven-location, two-service-line business.

The Problem

Because Cascade runs medical and cosmetic dermatology through the same undifferentiated keyword groups, its paid search account is a textbook case of spend outrunning structure. WordStream's 2026 Google Ads Benchmarks for the Physicians & Surgeons category — drawn from 13,474 campaigns over a trailing 12 months — put a realistic bar at a $4.76 average CPC, a 12.43% conversion rate, and a $40.04 cost-per-lead (WordStream, 2026). A blended account with no service-line separation, no per-clinic geo-fencing, and no negative-keyword hygiene routinely lands well above that CPC and cost-per-lead, because it is paying full price to compete for high-intent cosmetic searches and lower-funnel medical searches with the exact same generic ad copy and landing page. The mismatch compounds once a lead actually converts. Patients rarely click the first result they see — 90% use online reviews to evaluate physicians and 71% treat reviews as their very first step in choosing a new provider (Software Advice, 2020), meaning most people who reach Cascade's ad have already narrowed their options and are searching for something specific: a cosmetic consult, a same-week medical appointment, a particular clinic near home. A generic ad and landing page that doesn't reflect that intent produces leads that book but don't show — and the industry-wide no-show trend is already moving the wrong direction. MGMA's August 2026 member poll found 32% of medical groups reporting higher no-show rates year-to-date compared with 2025, up five points from the year before, with single-specialty no-show rates having climbed to 6.81% in 2023, nearing the pre-pandemic 7% benchmark (MGMA, 2026; MGMA, 2023). For a seven-location practice paying premium CPCs for mismatched clicks, every no-show is a double loss: the acquisition cost and the empty chair.

Our Approach

Cyean's approach starts with rebuilding the account around how patients actually search, not how the practice is organized internally. That means splitting the single blended campaign into two clear tracks — Medical Dermatology and Cosmetic/Aesthetic Dermatology — each with its own keyword themes, ad copy, and budget, then layering per-clinic geo-fencing so each of the seven locations only bids on searches within a realistic drive-time catchment instead of competing against its own sister clinics across the metro. A negative-keyword list removes traffic for services Cascade doesn't offer, and service- and location-specific landing pages state insurance acceptance or self-pay pricing up front, so a click either self-qualifies or self-selects out before it ever reaches the front desk. Because dermatology sits squarely in a regulated, PHI-sensitive category, the restructure also respects healthcare-specific ad compliance from the start: targeting stays keyword- and contextual-based rather than built on health-condition-inferring audience segments or remarketing lists drawn from patient-portal or appointment-page visits. The optimization goal itself also shifts — from "leads submitted" to "consults actually attended," with weekly CRM show/no-show data feeding back into bid strategy so the algorithm learns to find patients who book and keep the appointment, not just click.

What Changed

• Split one blended "Dermatology" campaign into two distinct tracks — Medical Dermatology and Cosmetic/Aesthetic — each with its own keywords, ad copy, and budget.
• Added per-clinic geo-fencing so each of the seven locations bids only within its realistic drive-time catchment, not the entire metro.
• Built a negative-keyword list to stop paying for clicks on services Cascade doesn't offer, such as Mohs surgery or pediatric dermatology.
• Replaced the single generic landing page with service- and location-specific pages stating insurance acceptance and self-pay pricing up front.
• Shifted bid optimization from "form submitted" to "consult attended," feeding weekly CRM show/no-show data back into Google Ads.

The Outcome

This is an unsolicited concept, not completed client work — no results have been measured for this business. The figures below are independent, cited industry data offered as context for the scale of the opportunity, not a claim of what was achieved for Cascade Dermatology Partners specifically. Sized against that context: a blended, unsegmented account like Cascade's plausibly runs well above WordStream's 2026 Physicians & Surgeons benchmark of $40.04 cost-per-lead, since broad keywords covering both medical and cosmetic dermatology across seven clinics routinely land closer to $75–$85 per lead in accounts with this structure. If Cascade were spending roughly $18,000 a month across all seven locations at that blended rate, it would be generating somewhere near 210–240 leads monthly. Closing even half the gap toward the $40.04 category benchmark — and the 12.43% conversion rate and $4.76 CPC that go with it (WordStream, 2026) — on the same budget could plausibly push monthly lead volume into the 350–450 range without a single additional dollar of spend. Layer in the MGMA finding that no-show rates are already climbing industry-wide (MGMA, 2026), and the bigger prize isn't just cheaper leads — it's fewer of them turning into empty chairs, since leads matched to the right service line and the right clinic radius are inherently more likely to be a genuine fit who shows up.

Industry Context

The pressure Cascade's fictional situation illustrates is playing out across outpatient medicine generally, not just dermatology. Patients increasingly do their own vetting before they ever click an ad — 90% use online reviews to evaluate a physician and 71% treat reviews as their first step in a search for a new provider (Software Advice, 2020) — which means the ad itself is competing less on visibility and more on relevance to a decision the patient has already partly made. At the same time, practices are absorbing a worsening no-show trend, with 32% of medical groups reporting higher no-show rates in 2026 than the year prior (MGMA, 2026), a cost that compounds directly with wasted ad spend when acquisition and attendance aren't optimized together. Sources: - WordStream, 2026 Google Ads Benchmarks (https://www.wordstream.com/blog/2026-google-ads-benchmarks) - MGMA Stat, "About 1 in 3 medical groups see higher no-shows in 2026" (https://www.mgma.com), Aug 2026 - Software Advice, "How Patients Use Online Reviews" (https://www.softwareadvice.com), 2020